Drugs / Hemp
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06159686 | Sep → Dec 2023 | — | Thammasat University Hospital | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hemp | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06159686 ↗ |
| Action | Inhibit | “inhibits mast cell differentiation, aggregation, and histamine release” NCT06159686 ↗ |
| Route | Topical | “Especially when applied topically” PMID 39328960 ↗ Aug 2024 |